• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Tamoxifen Citrate

Tamoxifen Citrate

Product ID T0250
Cas No. 54965-24-1
Purity ≥98%
Product Unit SizeCostQuantityStock
500 mg $71.50 In stock
1 g $142.90 In stock
5 g $375.60 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Tamoxifen is a selective estrogen receptor modulator (SERM) that acts as an ER agonist in the endometrium and as an ER antagonist in breast tissue; it also inhibits PKC. Tamoxifen exhibits anticancer chemotherapeutic, anti-angiogenic, anti-osteoporotic, and antipsychotic activities. Tamoxifen is also a prodrug, transformed into the active metabolite 4-hydroxytamoxifen in vivo. Tamoxifen shows some benefit in clinical settings in the treatment of bipolar I disorder and other mood disorders. In animal models, tamoxifen decreases blood vessel formation and inhibits angiogenesis. In osteoclasts, this compound induces apoptosis by increasing expression of FasL. Additionally, tamoxifen acts as a functional inhibitor of acid sphingomyelinase (FIASMA).

Product Info

Cas No.

54965-24-1

Purity

≥98%

Formula

C26H29NO • C6H8O7

Formula Wt.

563.64

Chemical Name

(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N- dimethylethylamine citrate

IUPAC Name

2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N, N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid InChI: InChI=1S/C26H29NO.C6H8O7/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14- 22)23-15-17-24(18-16-23)28-20-19-27(2)3;7-3(8)1-6(13, 5(11)12)2-4(9)10/h5-18H,4,19-20H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11, 12)/b26-25-;

Synonym

Kessar, Nolvadex, Taxus, Zynoplex, Zemide

Melting Point

143-146°C

Solubility

Slightly soluble in water. Soluble in ethanol, methanol or acetone.

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

T0250 MSDS PDF

Info Sheet

T0250 Info Sheet PDF

References

Yildiz A, Guleryuz S, Ankerst DP, et al. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry. 2008 Mar;65(3):255-63. PMID: 18316672.

Krum SA, Miranda-Carboni GA, Hauschka PV, et al. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 2008 Feb 6;27(3):535-45. PMID: 18219273.

Steiner AZ, Terplan M, Paulson RJ. Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis. Hum Reprod. 2005 Jun;20(6):1511-5. PMID: 15845599.

Blackwell KL, Haroon ZA, Shan S, et al. Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models. Clin Cancer Res. 2000 Nov;6(11):4359-64. PMID: 11106254.

Jordan VC. Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol. 1993 Oct;110(2):507-17. PMID: 8242225.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • J766160

    JTE907

    Selective Cannabinoid receptor 2(CB2) inverse a...

    ≥98%
  • O7332

    OSI-027

    mTOR inhibitor.

    ≥99%
  • L0248

    Laminin Peptide YIGSR

    Laminin-derived peptapeptide.

    ≥98%
  • M5752

    Monastrol

    Pyrimidine derivative; kinesin Eg5 inhibitor.

    ≥95%
  • P2856

    Phorbol-12,13-dibutyrate

    PKC and PKD activator, carcinogen.

    ≥98%
  • M9634

    Myriocin

    Atypical amino acid found in Isaria sinclairi, ...

    ≥99%, TLC
  • R2513

    RGDS

    Tetrapeptide, binds cell surface integrins.

    ≥95%
  • L5822

    Lofexidine Hydrochloride

    α2-adrenergic agonist.

    ≥98%
  • Z0252

    Zanamivir

    Neuraminidase inhibitor.

    ≥98%
  • A985136

    AZD5991

    Mcl-1 inhibitor

    ≥99%
  • R0161

    Rapamycin

    Macrolide originally produced by Streptomyces; ...

    ≥99%
  • C0252

    Canertinib Dihydrochloride

    EGFR inhibitor.

    ≥98%
  • M1564

    S-Methyl-L-cysteine

    Antioxidant found in Brassicaceae family plants...

    ≥99%
  • S9775

    Systemin

    Peptide hormone found in Solanaceae family plan...

    ≥95%
  • C0254

    Candesartan Celexetil Ester

    AT1 inhibitor.

    ≥98%
  • P9869

    Pyridoxine Hydrochloride

    Vitamin B6 derivative, antioxidant.

    ≥98%
  • T0114

    Taxinin M

    Taxane found in Taxus; DNA polymerase inhibitor...

    ≥98%
  • N3448

    Nimodipine

    L-type Ca2+ channel blocker.

    ≥98%
  • I7341

    Isoniazid

    Nicotinic acid derivative; InhA inhibitor.

    ≥98%
  • C0278

    (+)-Catechin

    Flavanol originally found in Camilla (green tea...

    ≥99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only